Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Memory and Attention in MCI
NCT02326038Phase 4Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in Mild Cognitive Impairment (MCI), sponsored by Maastricht University Medical Center+. Status: unknown.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT02326038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02326038.